Optos Versus Indirect Ophthalmoscopy for ROP Screening Examination (Optos vs BIO Study)
Impact of Retinopathy of Prematurity Screening Examination on Cardiorespiratory Indices - A Comparison of Optos Ultra-Widefield Retinal Imaging and Binocular Indirect Ophthalmoscopy
1 other identifier
interventional
50
1 country
1
Brief Summary
ROP is a preventable cause of blindness in premature infants. It is routinely screened for by using an indirect ophthalmoscope, a scleral depressor, and a condensing lens. This method of screening can cause significant cardiorespiratory distress to infants. A new camera (Optos California) has recently been used to image infants with different severities of ROP. The Optos California is capable of capturing up to 200 degrees of retina in a single image without contact with the eye. The non eye contact nature of the Optos California may cause less distress to infants who are due a ROP screening examination. The present study is to compare the impact of ROP screening examination between the Optos retinal camera and conventional binocular indirect ophthalmoscopy using cardiorespiratory indices (such as heart rate, oxygen saturations, blood pressure, and respiratory rate) as a measure of distress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2018
CompletedFirst Submitted
Initial submission to the registry
February 26, 2020
CompletedFirst Posted
Study publicly available on registry
March 2, 2020
CompletedMarch 2, 2020
February 1, 2020
5 months
February 26, 2020
February 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Blood pressure (BP)
Blood pressure (BP)
Baseline to 10 minutes following completion of both interventions
Number of infants that develop bradycardia
Defined as less than 100 beats per minute
Baseline to 10 minutes following completion of both interventions
Oxygen saturation
Number of infants who develop oxygen saturations below 85%
Baseline to 10 minutes following completion of both interventions
Development of respiratory distress
Number of infacnts who develop respiratory distress, defined as respiratory rate less than 30 breaths per minute
Baseline to 10 minutes following completion of both interventions
Secondary Outcomes (1)
Determine and compare time taken to perform interventions
During intervention
Study Arms (2)
Standard then Intervention
EXPERIMENTALInfant will undergo standard method of examination with binocular indirect opthalmoscope (BIO) followed by retinal imaging with Optos ultra-wide field retinal imaging device.
Intervention then Standard
EXPERIMENTALInfant will undergo retinal imaging with Optos ultra-wide field retinal imaging device followed by standard method of examination with binocular indirect opthalmoscope (BIO).
Interventions
retinal imaging device
Eligibility Criteria
You may qualify if:
- Infants eligible for routine ROP screening using UK ROP screening guidelines (Any infant born at or before 32 weeks gestation and/or weigh 1500 grams or less).
- Infants with parents who have conversational English and who can give written informed consent.
You may not qualify if:
- Infants not eligible for routine ROP screening under UK ROP screening guidelines.
- Infants who are deemed not well enough by a consultant neonatologist (SO) for retinal examination or retinal imaging.
- Any premature infant with media opacities that prevents adequate visualisation of the retina.
- Inability of the parents to understand verbal and written English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospitals of Derby & Burton NHS Foundation Trust
Derby, Derbyshire, DE22 3DT, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2020
First Posted
March 2, 2020
Study Start
August 14, 2017
Primary Completion
January 22, 2018
Study Completion
January 22, 2018
Last Updated
March 2, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share